Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer
Clinical trial NCT05810792 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05810792
- Sponsor
- Sahlgrenska University Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2027-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.